Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study

BACKGROUND: The efficacy and safety of direct-acting antivirals (DAAs) for treating hepatitis C virus (HCV)-infected renal transplant recipients (RTRs) has not been determined. METHODS: We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials and assessed the quality of eli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Keliang, Lu, Pei, Song, Rijin, Zhang, Jiexiu, Tao, Rongzhen, Wang, Zijie, Zhang, Wei, Gu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627830/
https://www.ncbi.nlm.nih.gov/pubmed/28746204
http://dx.doi.org/10.1097/MD.0000000000007568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627830/
https://www.ncbi.nlm.nih.gov/pubmed/28746204
http://dx.doi.org/10.1097/MD.0000000000007568

Ejemplares similares